Kymera Therapeutics, Inc.

7 Live Marks

15 on record

Corp.

First Filed:Nov 22, 2018Latest Filed:May 5, 2025Address:500 North Beacon Street, 4th Floor, Watertown, MA 02472, US

Portfolio Overview

Top Classes

Class 5

Pharmaceuticals

10(67%)

Class 42

Software, IT Services & Scientific Research

5(33%)

TTAB Proceedings

Proceedings

As Plaintiff

0(0%)

As Defendant

1(100%)

Extensions of Time

Top Firms

Trademark Activity Timeline(2018 – 2026)

Trademark Portfolio

15 results

(current & previous marks)

Refine by Mark/Description🔽

Filed

Registered

Last Activity

Trademark

Word

PENDING

Owner:

Serial:99170049

Filed:May 5, 2025

Classes:5

Description: Therapeutic agents, namely pharmaceutical preparations for use in clinical trials for the treatment of atopic dermatitis, asthma, chronic obstructive pulmonary disease, prurigo nodularis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, bullous pemphigoid, chronic spontaneous urticaria, lupus, Sjogren's Syndrome, inflammatory bowel disease, and dermatomyositis

KYMERA

Trademark

Combined

PENDING

Owner:

Serial:98790441

Filed:Oct 8, 2024

Classes:5

Description: House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases

IRAKIMID

Trademark

Word

ABANDONED

Owner:

Serial:98044278

Filed:Jun 15, 2023

Classes:5

KYMERA THERAPEUTICS

Trademark

Word

PENDING

Owner:

Serial:97832494

Filed:Mar 10, 2023

Classes:5

Trademark

Combined

REGISTERED

Owner:

Serial:97204204

Filed:Jan 5, 2022

Classes:5

Registration:8439173

Registered:Sep 15, 2026

Description: Class 5: Pharmaceutical and medical preparations for the treatment of immune inflammatory diseases and autoimmune diseases; Pharmaceutical therapeutics for the treatment of immune inflammatory diseases and autoimmune diseases
Class 42: Research and development of therapeutic drugs for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; Research and development of therapeutic antibodies and pharmaceuticals; Research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services and drug discovery services; Medical research for development of therapeutic modalities for treatment of diseases; Custom design and development of biochemical assays and chemical reagents for use in scientific and biomedical research; Clinical studies, namely, clinical research in the field of oncology, immune oncology, and autoimmune diseases; Preclinical and clinical development of therapeutic products being pharmaceutical preparations and medicines

KYMERA

Trademark

Combined

ABANDONED

Owner:

Serial:90320564

Filed:Nov 16, 2020

Classes:5

KYMERA

Trademark

Combined

REGISTERED

Owner:

Serial:90981116

Filed:Nov 16, 2020

Classes:42

Registration:7559572

Registered:Nov 5, 2024

Description: Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products